Engineered inulin-based hybrid biomaterials for augmented immunomodulatory responses

Carbohydr Polym. 2024 Sep 15:340:122311. doi: 10.1016/j.carbpol.2024.122311. Epub 2024 May 23.

Abstract

Modified biopolymers that are based on prebiotics have been found to significantly contribute to immunomodulatory events. In recent years, there has been a growing use of modified biomaterials and polymer-functionalized nanomaterials in the treatment of various tumors by activating immune cells. However, the effectiveness of immune cells against tumors is hindered by several biological barriers, which highlights the importance of harnessing prebiotic-based biopolymers to enhance host defenses against cancer, thus advancing cancer prevention strategies. Inulin, in particular, plays a crucial role in activating immune cells and promoting the secretion of cytokines. Therefore, this mini-review aims to emphasize the importance of inulin in immunomodulatory responses, the development of inulin-based hybrid biopolymers, and the role of inulin in enhancing immunity and modifying cell surfaces. Furthermore, we discuss the various approaches of chemical modification for inulin and their potential use in cancer treatment, particularly in the field of cancer immunotherapy.

Keywords: Fructan; Hybrid biopolymers; Immunomodulatory responses; Inulin.

Publication types

  • Review

MeSH terms

  • Animals
  • Biocompatible Materials* / chemistry
  • Biocompatible Materials* / pharmacology
  • Humans
  • Immunotherapy / methods
  • Inulin* / chemistry
  • Inulin* / pharmacology
  • Neoplasms* / drug therapy
  • Neoplasms* / immunology
  • Neoplasms* / therapy

Substances

  • Inulin
  • Biocompatible Materials